GI
LLY icon

GS Investments’s Eli Lilly LLY Stock Holding History

GS Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Sell
2,011
-1,004
-33% -$1.03M 1.74% 24
2026
Q1 		$2.77M Buy
3,015
+13
+0.4% +$13.2K 1.59% 25
2025
Q4 		$3.23M Sell
3,002
-60
-2% -$57.4K 1.75% 25
2025
Q3 		$2.34M Buy
3,062
+41
+1% +$30.5K 1.16% 34
2025
Q2 		$2.35M Buy
3,021
+144
+5% +$112K 1.04% 37
2025
Q1 		$2.38M Buy
+2,877
New +$2.39M 1.12% 34

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GS Investments's LLY Position: Q2 2026 in Review

GS Investments reduced its Eli Lilly (LLY) stake by 33% in Q2 2026, selling an estimated $1.03M and leaving 2,011 shares worth $2.41M. The position accounts for 1.74% of the portfolio, ranked #24.

GS Investments first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.23M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GS Investments held 2,011 shares of Eli Lilly worth $2.41M as of Q2 2026.
  • GS Investments sold 1,004 Eli Lilly shares in Q2 2026, an estimated $1.03M.
  • Eli Lilly made up 1.74% of GS Investments's portfolio in Q2 2026, its #24 holding.
  • GS Investments first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • GS Investments's Eli Lilly position peaked at $3.23M in Q4 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GS Investments's 13F filing for Q2 2026, filed 6 Aug 2026.